# Fluarix Immunogenicity and Safety Trial

> **NCT00100399** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 1050 (—)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Fluarix

## Key facts

- **NCT ID:** NCT00100399
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 1050 (—)
- **Last updated:** 2010-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00100399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00100399, "Fluarix Immunogenicity and Safety Trial". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00100399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*